Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Account Payables (2022)

Orchestra BioMed Holdings (OBIO) has disclosed Change in Account Payables for 1 consecutive years, with $95369.0 as the latest value for Q4 2022.

  • On a quarterly basis, Change in Account Payables changed N/A to $95369.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $375542.0, a N/A change, with the full-year FY2022 number at $375542.0, up 3123.2% from a year prior.
  • Change in Account Payables was $95369.0 for Q4 2022 at Orchestra BioMed Holdings, down from $110904.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $110904.0 in Q3 2022 to a low of $67050.0 in Q2 2022.